IGILUC 2026 (International Gastrointestinal, Liver, and Uro-Oncology Conference)
2026-01-22 - 2026-01-23 | Hilton Cairo Heliopolis, El-Orouba, Sheraton Al Matar, El Nozha, Cairo, 11361, Egypt
The IGILUC 2026 (International Gastrointestinal, Liver, and Uro-Oncology Conference) is a high-level scientific meeting scheduled for January 22–23, 2026, in Cairo.
The congress focuses on bridging the gap between rapid scientific breakthroughs and daily clinical implementation, with a specific emphasis on multidisciplinary care for GI, hepatic, and urological malignancies. The technical program features a blend of precision oncology lectures, surgical workshops, and a holistic approach to patient management, including specialized tracks for geriatric and psycho-oncology.
Register.

NRG Oncology Winter Meeting 2026
2026-01-22 - 2026-01-24 | Hilton San Francisco Union Square, 333 O'Farrell St, San Francisco, CA 94102,
The NRG Oncology Winter Meeting 2026 will be held from January 22-24, 2026, at Hilton San Francisco Union Square in San Francisco, USA. This semiannual event brings together oncology researchers, clinicians, and professionals to discuss advances in clinical trials, cancer treatment protocols, translational research, and quality of life interventions.
Attendees can expect a range of scientific sessions, protocol development workshops, networking events, and opportunities to engage in collaborative projects aimed at improving patient outcomes in cancer care. The meeting is a key forum for launching new studies, reviewing current data, and fostering innovation within the NRG Oncology research community.

EASL Liver Cancer Summit 2026
2026-01-22 - 2026-01-24 | Edinburgh International Conference Centre (EICC), 150 Morrison St, Edinburgh, EH3 8EE
The EASL Liver Cancer Summit 2026 is a multidisciplinary scientific meeting dedicated to the study and management of primary liver cancers, specifically hepatocellular carcinoma (HCC) and cholangiocarcinoma.
Scheduled for January 22–24, 2026, in Edinburgh, the summit provides a technical forum for hepatologists, oncologists, surgeons, and interventional radiologists to discuss advancements in molecular pathogenesis, genomic profiling, and emerging systemic therapies. Organized by the European Association for the Study of the Liver (EASL), the event includes peer-reviewed abstract presentations and sessions on healthcare resource optimization and patient advocacy.
Register.

ANCO's Clinical Cancer Update 2026
2026-01-23 - 2026-01-25 | Everline Resort & Spa Lake Tahoe, 400 Resort Road, Olympic Valley, CA, 96146, United States
ANCO’s Clinical Cancer Update 2026, taking place January 23–25, 2026, at the Everline Resort and Spa, will highlight the latest breakthroughs in cancer treatment across multiple specialties, including breast, gastrointestinal, genitourinary, lung, hematologic, and CNS cancers.
The three-day meeting offers cutting-edge clinical content, opportunities for professional networking, and insights into translational science, chemotherapy, radiation, and surgical protocols, providing up to 12.25 AMA PRA Category 1 Credits™ for healthcare providers.
Register here.

Cytopenias Post CAR T-Cells: ALL-Hematotox
2026-01-23 09:00 - 10:00 (America/New_York)
The ALRCaN (Acute Leukemia Research and Care Network) webinar, titled “Cytopenias Post CAR T-Cells: ALL-Hematotox“, is scheduled for Friday, January 23, 2026, from 09:00 to 10:00 AM ET.
Presented by Dr. Nirali N. Shah, this session focuses on the newly developed ALL-Hematotox (ALL-HT) score, a clinical tool designed to predict hematological toxicity specifically in patients with B-cell acute lymphoblastic leukemia (B-ALL) following CAR T-cell therapy. This weekly collegial gathering, hosted by Resonance, allows experts to share best practices and clinical insights to optimize post-infusion care and patient outcomes.

ESMO Advanced Course on CDK4/6 Inhibitors in Breast Cancer Management 2026: Jeddah
2026-01-24 | Jeddah, Saudi Arabia
The ESMO Advanced Course on CDK4/6 Inhibitors in Breast Cancer Management 2026 is an intensive, single-day educational symposium scheduled for January 24, 2026, in Jeddah, Saudi Arabia.
Organized by the European Society for Medical Oncology (ESMO), this event is designed as a closed course specifically for invited medical oncologists and oncology fellows from the Middle East. The program focuses on the biological function of CDK4/6 in breast cancer and the practical integration of CDK4/6 inhibitors into the treatment landscape for both early-stage and metastatic hormone receptor-positive (HR+) / HER2-negative breast cancer.

A Global Collaborative Forum on Cancer Care
2026-01-24
The A Global Collaborative Forum on Cancer Care Edition III, organized by the Jarurat Care Foundation in collaboration with AstraZeneca, is a high-level scientific webinar scheduled for January 24, 2026.
This edition focuses on the critical question of therapeutic selection for Unresectable Hepatocellular Carcinoma (HCC) in the rapidly evolving landscape of immunotherapy. The forum features a prestigious international keynote by Dr. Renuka Iyer from the Roswell Park Comprehensive Cancer Center and the NCCN panel, alongside leading oncologists from top-tier institutions such as MD Anderson and HN Reliance.

OncoDaily Cervical Cancer Summit 2026
2026-01-24 10:00 - 17:00 (Europe/Paris)
The OncoDaily Cervical Cancer Summit 2026 is a global virtual medical congress dedicated entirely to cervical cancer screening, diagnosis, treatment, and elimination strategies, bringing together experts from all continents to discuss current standards of care and future directions on January 24, during Cervical Cancer Awareness Month.
The OncoDaily Cervical Cancer Summit is designed for medical oncologists, gynecologic oncologists, radiation oncologists, radiologists, surgeons, researchers, and public health professionals seeking a comprehensive and up-to-date global perspective on cervical cancer management in 2026.
The meeting emphasizes evidence-based practice, multidisciplinary collaboration, and implementation science, aligning clinical advances with global elimination goals, including the 90-70-90 targets.
Register.

The All-Island Forum on Cancer Data 2026
2026-01-26 - 2026-01-27 | Queen’s University Belfast, University Rd, Belfast BT7 1NN, United Kingdom, Belfast, Northern Ireland, BT7 1NN, United Kingdom
The All-Island Forum on Cancer Data, themed “From Data to Impact: Roadmap for Cancer Data,” will be held on 26–27 January 2026 at Queen’s University Belfast. This two-day event will bring together researchers, clinicians, and data experts from across Ireland and Europe to explore the transformative role of data in advancing cancer research, treatment, and care.
Key topics to be addressed include research through data innovation, improving access to clinical trials and medicines, ethical data sharing, and tackling the real-world data skills gap. The forum will also feature the inaugural OHDSI Ireland Node Joint Meeting and Workshop, marking an important step toward building an integrated cancer data ecosystem across the island. Registration details and participation fees have not yet been announced.
You can find more posts featuring Queen’s University Belfast on OncoDaily.

Spotlight on the Cancer Cell: Intrinsic Properties and Vulnerabilities for Therapeutics
2026-01-26 - 2026-01-29 | Embassy Suites by Hilton Raleigh Durham Research Triangle, 201 Harrison Oaks Blvd, Cary, NC, 27513, United States
The Keystone Symposia conference titled “Spotlight on the Cancer Cell: Intrinsic Properties and Vulnerabilities for Therapeutics“ will take place from January 26–29, 2026, at the Embassy Suites by Hilton Raleigh Durham Research Triangle in Cary, North Carolina, United States.
This meeting, organized by Scientific Organizers including Anwesha Dey, Laura D. Attardi, and Mariam Jamal-Hanjani, is dedicated to exploring the cell-intrinsic mechanisms that drive carcinogenesis and cancer progression, with a distinct focus on understanding how genetic, epigenetic, and metabolic changes within cancer cells create vulnerabilities that can be targeted for therapeutic interventions, thereby inspiring new approaches to cancer treatment.

8th Annual Us vs. HPV Prevention Week 2026
2026-01-26 - 2026-01-30
The 8th Annual Us vs. HPV Prevention Week is a global virtual conference scheduled for January 26–30, 2026.
Organized by the American Medical Women’s Association (AMWA) and the Global Initiative Against HPV and Cervical Cancer (GIAHC), the event focuses on the theme “Building Community Around HPV Prevention and Related Disease Management.” This virtual summit highlights significant public health milestones, including the global adoption of single-dose HPV vaccine schedules and the 2026 nationwide rollout of at-home HPV self-collection tests like the Teal Wand.
Register.

CAR T-Cell Therapy: Health Care Resource Utilization + Costs in DLBCL Patients
2026-01-27
The webinar “CAR T-Cell Therapy: Health Care Resource Utilization + Costs in DLBCL Patients,” hosted by NCODA, is a CE-accredited session scheduled for January 27, 2026, at 2:00 PM EST.
Led by Madelyn Floysand, PharmD, the program provides a deep dive into real-world evidence from a 2025 Journal of Managed Care and Specialty Pharmacy study regarding the economic and operational impact of Chimeric Antigen Receptor T-cell therapy in Diffuse Large B-Cell Lymphoma.
The session is designed to help oncology professionals compare resource utilization – such as ICU stays and outpatient visits – between inpatient and outpatient administration models, offering practical insights to refine patient selection and interdisciplinary workflow planning.

ESMO Guidelines: Real World Cases - Webinar Series: Colorectal Cancer 2026
2026-01-28
The ESMO Guidelines: Real World Cases – Webinar Series: Colorectal Cancer 2026 is a live virtual event focused on discussing real-world clinical cases and applying ESMO guidelines to the management of colorectal cancer. This webinar is scheduled to take place virtually on January 28, 2026, at 18:30 CET (Central European Time).
Register.

Foundations in Immunotherapy in the Oncology Population: Strategies for Clinical Application and Patient Management
2026-01-28 08:00 - 16:45 (America/Halifax)
The Memorial Sloan Kettering Cancer Center (MSKCC) is hosting a one-day live virtual CME program, “Foundations in Immunotherapy in the Oncology Population: Strategies for Clinical Application and Patient Management,” on Wednesday, January 28, 2026, from 8:00 AM to 4:45 PM ET.
This comprehensive course is designed for physicians, advanced practice providers (APPs), and allied health professionals, offering a review of foundational concepts and emerging advances in cancer immunotherapy, including immune checkpoint blockade, CAR T-cell therapy, TIL, and BiTE therapies.
Register.

Hope, Hurdles and the Way Forward: The Global Drive to End Cervical Cancer
2026-01-28 10:00 - 11:15 (Europe/Paris)
The International Day Webinar on January 28, 2026, titled “Hope, Hurdles and the Way Forward: The Global Drive to End Cervical Cancer,” serves as the focal point of the 8th Annual Us vs. HPV Prevention Week. Hosted by the American Medical Women’s Association (AMWA) and the Global Initiative Against HPV and Cervical Cancer (GIAHC), this virtual session is strategically timed at 10:00–11:15 AM EST to facilitate a broad global audience.
Register.

Joint Meeting of ICIS and ORMIS: From Oman to the World: Defining New Horizons in Medical Imaging
2026-01-30 - 2026-01-31 | Grand Hyatt Muscat, Way no. 3032, As Saruj St, Muscat, Muscat Governorate, 133, Oman
The Joint Meeting of ICIS and ORMIS: From Oman to the World: Defining New Horizons in Medical Imaging is an in-person satellite event scheduled for January 30–31, 2026, starting at 7:30 AM, taking place at the Grand Hyatt in Muscat, Sultanate of Oman.
This collaborative meeting between the International Cancer Imaging Society (ICIS) and the Oman Radiology and Molecular Imaging Society (ORMIS) aims to foster the exchange of knowledge, showcase the latest trends in cancer imaging from head to toe, and promote best practices that will enhance patient care and outcomes.
The two-day conference will feature interactive, case-based learning, focusing on cutting-edge technologies and practical clinical applications, offering a unique platform to strengthen global and regional networks in medical imaging.
Register.

Journal Club with Scott Howard - Resonance
2026-01-30 09:00 - 10:00 (America/New_York)
The ALRCaN Global webinar series presents “Journal Club with Scott,” featuring Dr. Scott Howard on Friday, January 30, 2026, from 09:00 AM to 10:00 AM EST.
Hosted by Resonance Health, the journal club serves as a collaborative platform for healthcare professionals to analyze new data, discuss emerging trends, and share diverse perspectives on optimizing patient care through evidence-based practice.

ASCO Virtual Town Hall: From Mentorship to Manuscript - Building Academic Success in Oncology in LMICs
2026-01-30 09:30 - 11:30 (America/New_York)
The ASCO Trainee and Early Career (TEC) Town Hall: From Mentorship to Manuscript – Building Academic Success in Oncology in LMICs is a specialized virtual workshop designed to support the professional development of oncologists in resource-limited settings.
Scheduled for January 30, 2026, this session focuses on the unique challenges and opportunities of building an academic career in Low- and Middle-Income Countries (LMICs). The technical program provides practical guidance on the academic lifecycle, from the initial identification of high-impact research questions to the complexities of international mentorship and the successful publication of manuscripts in global oncology journals.
Register.

2026 AAOM Winter Meeting
2026-01-31
The 2026 American Academy of Oral Medicine (AAOM) Winter Meeting, themed “Oral-Systemic Synergy: Collaborative Perspectives in Oral Health,” will be held on Saturday, January 31, 2026. This event will be conducted virtually (online).
The meeting is eligible for 5 CERP Continuing Education (CE) credits and is designed to deliver essential updates and contemporary trends in the field of oral medicine. The program includes a specific collaborative session on “Oncology, Immunotherapy, and Oral Complications,” reflecting the meeting’s focus on the interdisciplinary approach to oral health and systemic diseases.
Register.

Best of Hematology and Breast Cancer 2026, Augusta
2026-01-31 | Crowne Plaza North Augusta by IHG, 1060 Center St, North Augusta, SC, 29841, United States
The Best of Hematology and Breast Cancer 2026, Augusta conference, offering 6.75 Continuing Medical Education (CME) credits, is scheduled for January 31, 2026.
The event will take place at the Crown Plaza located at 1060 Center Street, North Augusta, South Carolina, United States. Hosted by Binaytara, the conference is part of a series of educational projects focused on improving cancer care by disseminating the latest advances in the fields of hematology and breast cancer to medical professionals.
Register.

ESMO in Focus Immuno-Oncology Bulgaria 2026
2026-01-31 | InterContinental Sofia, 4 Narodno Sabranie Square, Sofia, Sofia City, 1000, Bulgaria
The ESMO in Focus Immuno-Oncology Bulgaria 2026 is a licensed scientific conference organized by the Bulgarian Scientific Society for Immuno-Oncology (BSIO) in collaboration with the European Society for Medical Oncology (ESMO).
Scheduled for January 31, 2026, in Sofia, the meeting serves as a regional forum to disseminate the latest clinical data and therapeutic breakthroughs presented at the ESMO Immuno-Oncology Congress 2025 held in London. The technical program focuses on the evolution of personalized immunotherapy, emerging biomarkers for checkpoint inhibitor response, and the clinical management of immune-related adverse events across various solid tumors.
Register.

The 3rd Best of ASTRO Gulf 2026
2026-01-31 | Anantara Downtown Dubai Hotel, Al Abraj Street, Dubai, 71847, United Arab Emirates
The 3rd Best of ASTRO Gulf 2026 is scheduled for Saturday, January 31, 2026, at the Anantara Downtown Dubai Hotel in the UAE. This officially licensed program, organized by the Emirates Oncology Society (EOS) and the Radiation Oncology Workgroup, is designed to bring the most practice-changing research from the ASTRO 2025 Annual Meeting to the regional community.
Chaired by Prof. Humaid Al Shamsi, Dr. Ibrahim Abu-Gheida, and Dr. Majed Alghamdi, the event features expert-led discussions on cancer sites, including breast, gastrointestinal, genitourinary, and lung, alongside innovative sessions on radiogenomics. Notable speakers such as Dr. Eter Natelauri and Dr. Tamer Refaat are set to present, with the scientific committee further bolstered by experts like Dr. Rana, Dr. Thuraya, and Dr. Falah. Attendees are also eligible to attend the Best of SABCS UAE the following day, making it a comprehensive weekend for oncology updates.

Insights from the 67th ASH Annual Meeting - Boston
2026-01-31 - 2026-02-01 | The Westin Waltham Boston, 70 Third Ave., Waltham, MA, 02451, United States
This educational program, “Insights from the 67th ASH Annual Meeting – Boston,” is an independent, two-day Continuing Medical Education (CME) conference hosted by Horizon CME at The Westin Waltham Boston on January 31–February 1, 2026.
The program is designed for hematologists/oncologists, nurses, pharmacists, and other healthcare professionals and focuses on providing the latest science and education from the world’s premier hematology event.
Expert faculty will offer in-depth discussions and analyses of selected abstracts, focusing on practice-changing advances in the treatment of blood disorders and cancers, including sessions on Myelodysplastic Syndromes, Acute Leukemias, Lymphomas, Cell Therapy (including CAR-T), and Hematopoietic Stem Cell Transplantation. The event offers up to 9.75 AMA PRA Category 1 Credit™ and ABIM MOC points.
Register.

Insights from the 67th ASH Annual Meeting - Los Angeles
2026-01-31 - 2026-02-01 | Hyatt Regency Huntington Beach Resort And Spa, 21500 Pacific Coast Hwy, Huntington Beach, CA, 92648, United States
This educational program, “Insights from the 67th ASH Annual Meeting – Los Angeles,” is an independent, two-day Continuing Medical Education (CME) conference hosted by Horizon CME at the Hyatt Regency Huntington Beach Resort and Spa on January 31–February 1, 2026.
The program is designed for hematologists/oncologists, nurses, pharmacists, and other healthcare professionals and provides the latest science and education from the ASH Annual Meeting, with selected abstracts focusing on research and advances in hematology that will impact clinical practice and patient care. The event offers up to 9.75 AMA PRA Category 1 Credit™ and ABIM MOC points.
Register.

Optimising the Treatment Pathway in HER2+ Breast Cancer: From Neoadjuvant Therapy to Surgery
2026-02-02
The webinar “Optimising the treatment pathway in HER2-positive breast cancer: from neoadjuvant therapy to surgery” is a specialized educational session scheduled for February 2, 2026, at 18:00 CET.
Part of the European Union-funded DEFINITIVE project, this session examines the critical interface between systemic neoadjuvant management and evolving surgical standards for HER2-positive breast cancer. A multidisciplinary panel, including experts Monika Gräser and Gaia Griguolo with discussant Aleksandra Filipovic, will address evidence-based strategies for tailoring therapy and the clinical implications of treatment response on surgical decision-making.

10th Annual Conference of the Hellenic Cancer Federation (ELLOK)
2026-02-02 - 2026-02-04 | ZEUS Wyndham Grand Athens, Meg. Alexandrou 2, Athina (Athens), Attica, 104 37, Greece
The 10th Annual Conference of the Hellenic Cancer Federation (ELLOK), titled “The Human at the Center – Building bridges of care,” is scheduled to take place on February 2, 3, and 4, 2026. This key annual event, organized around World Cancer Day (February 4th), will be held at the Wyndham Grand Athens hotel.
The conference aims to highlight critical health policy issues and oncological care developments in Greece, seeking to promote dialogue and propose realistic solutions among the state, academic and scientific communities, the health industry, and patient representatives.
Register.

17th Annual SCOPE Summit
2026-02-02 - 2026-02-05 | Rosen Shingle Creek, 9939 Universal Blvd, Orlando, FL, 32819, United States
The 17th Annual SCOPE Summit (Summit for Clinical Ops Executives) is scheduled to take place from February 2–5, 2026, at the Rosen Shingle Creek in Orlando, Florida.
Organized by the Cambridge Healthtech Institute (CHI), this premier event for clinical trial innovation is expected to convene over 4,500 attendees from 30 countries, representing more than 1,200 companies across the pharma, biotech, and CRO sectors. The 2026 program features 30 conference tracks, including new spotlights on Market Access, Drug Safety, and Therapeutic Areas such as Oncology and CNS.

7th Edition of the Cancer Summit and Awards (2026)
2026-02-03 | New Delhi, India
The 7th Edition of the Cancer Summit and Awards (2026), organized by the Integrated Health and Wellbeing (IHW) Council and RAPID Global Cancer Alliance, continues its mission as a premier global platform for advancing oncology and patient-centered care.
Building on the success of the 2025 event, this edition focuses on the theme of “Living with Cancer in the 21st Century,” addressing the dual challenges of rising global incidence and the need for more equitable access to innovative treatments.
The summit serves as a critical nexus for oncologists, researchers, and policymakers to discuss breakthroughs in precision medicine, early detection technologies, and survivorship strategies.

10th Anniversary Liquid Biopsy for Precision Oncology Summit
2026-02-03 - 2026-02-05 | San Diego Marriott La Jolla, 4240 La Jolla Village Dr, La Jolla, CA 92037, La Jolla, California, CA, 92037, United States
The 10th Anniversary Liquid Biopsy for Precision Oncology Summit is the leading annual meeting organized by Hanson Wade, dedicated to accelerating the collaboration and progress of liquid biopsy technologies across the entire oncology drug development pipeline. The event, which carries the theme “Transforming Precision Therapies Through Robust Liquid Biopsy Testing,” is scheduled for February 3–5, 2026, and will be held in San Diego, California, at the San Diego Marriott La Jolla. It brings together experts from pharma, biotech, diagnostics, academia, and advocacy to share insights on ctDNA, MRD (Minimal Residual Disease) monitoring, multi-omic biomarkers, and strategies for overcoming regulatory and commercial barriers to widespread clinical adoption.
Secure your Free Pass.
Full Event Guide.
This article is sponsored by Hanson Wade Group.

A Call for an EU Budget that Delivers for Health, Cancer, and Rare Diseases
2026-02-03 10:00 - 11:30 (Europe/Paris) | Room 5E2, European Parliament, Rue Wiertz 60, Brussels (Bruxelles), 1047, Belgium
The event “A Call for an EU Budget that Delivers for Health, Cancer, and Rare Diseases“ is scheduled for Tuesday, February 3, 2026, from 10:00 to 11:30 CET at the European Parliament in Brussels.
Organized by the European Cancer Organisation on the eve of World Cancer Day, this meeting serves as a high-level advocacy platform to secure sustained political and financial support within the EU’s next long-term budget (Multiannual Financial Framework). During the session, a cross-party coalition of decision-makers will publish a position paper outlining the future of Europe’s Beating Cancer Plan, emphasizing the need to preserve its legacy and address the ongoing public health threat posed by cancer, childhood cancer, and rare diseases.
Register.
